Beraprost Impurities are a group of chemical compounds that are typically produced during the manufacturing process of Beraprost, a medication used to treat pulmonary arterial hypertension. These impurities may have varying degrees of toxicity and can affect the safety, efficacy, and stability of the medication. Analyzing and controlling the levels of Beraprost Impurities is an essential aspect of pharmaceutical quality control to ensure patient safety and compliance with regulatory standards.
